Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression
about
EMT or EMT-Promoting Transcription Factors, Where to Focus the Light?Phenotype switching in melanoma: implications for progression and therapy.MITF in melanoma: mechanisms behind its expression and activity.Neuroblastoma: molecular pathogenesis and therapy.Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma.Cell cycle control, DNA damage repair, and apoptosis-related pathways control pre-ameloblasts differentiation during tooth development.Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells.The transcription factor Zeb2 regulates development of conventional and plasmacytoid DCs by repressing Id2ZEB2 inhibits HBV transcription and replication by targeting its core promoter.ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.Melanoma cells revive an embryonic transcriptional network to dictate phenotypic heterogeneity.Microphthalmia-associated transcription factor expression levels in melanoma cells contribute to cell invasion and proliferation.Immunogenic, cellular, and angiogenic drivers of tumor dormancy--a melanoma view.Short stretches of rare codons regulate translation of the transcription factor ZEB2 in cancer cells.Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemia.NFATc2 is an intrinsic regulator of melanoma dedifferentiation.Abl kinase regulation by BRAF/ERK and cooperation with Akt in melanoma.E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulationSingle-cell gene expression signatures reveal melanoma cell heterogeneity.Potential therapeutic targets of epithelial-mesenchymal transition in melanoma.The master role of microphthalmia-associated transcription factor in melanocyte and melanoma biology.MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma.Critical role of glioma-associated oncogene homolog 1 in maintaining invasive and mesenchymal-like properties of melanoma cellsPlatelet-derived growth factor-C promotes human melanoma aggressiveness through activation of neuropilin-1.Melanoma Suppressor Functions of the Carcinoma Oncogene FOXQ1.miRNAs, Melanoma and Microenvironment: An Intricate Network.Genetic variation in the MITF promoter affects skin colour and transcriptional activity in black-boned chickens.Inducibly decreased MITF levels do not affect proliferation and phenotype switching but reduce differentiation of melanoma cells.Generation and characterization of mice for conditional inactivation of Zeb1.Pim-3 enhances melanoma cell migration and invasion by promoting STAT3 phosphorylation.miR-128 modulates chemosensitivity and invasion of prostate cancer cells through targeting ZEB1.The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer.Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation.Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors.Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.[Epigenetic regulation of gene expression in malignant melanoma].Genomic positional conservation identifies topological anchor point RNAs linked to developmental loci.SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma.
P2860
59a3ecac129460f159ec014f4caefed08cb641ed6241d2a0e733de97446b59758a1b26ac679800d375a5f01927c967da48d4341d131708a426869f637bf8cfd6ac203e19f8fa01ae7d68a7dc53861f337c15280274ca5c780e46bd2a1440afc0522b7bfd82d37724a9f03e9a19ee0edc2c3be200ae6bfe879fef58142669e5b35562a8baa35f95b2b9fdfac8eb7e758f539c533143ee91429636cbd35dd6d288ecd16e02768acea5dcb72244c7e3db8c042fcdc4f1ef0d898a180b710f70efdea6270bb6f34a5f73
P248
Q26995188-B8E3E6C4-884B-499B-B3C0-EEFD478E120EQ35081779-DC17C140-5EE7-4E49-9E2B-87A1A276FBC9Q35187734-0C0B4B8D-D70A-4520-B5C3-44DFAE9A1699Q35564199-BC4F4A5D-D662-45CD-BC39-E11E49A90F61Q35596369-95703103-6D9D-4B1A-8CDB-D276D2838987Q35743285-9C6C1FFA-7428-48AF-B382-E038726B27D5Q36126538-BAFD93C5-3881-4089-BBA8-B2F8480E24FFQ36299770-9B0E8953-433E-42A2-AD9B-99E0172BEEC9Q36949912-1468E760-C868-43CF-BC5E-4C362A1D64EFQ37085933-5962A43B-EFE5-41A9-A672-EAA3CC6EBECBQ37307458-8A29D2C0-14F6-4A19-AE99-F1B53470EC41Q37615918-F4E77A42-67A6-48E9-A239-3B26AEAADE60Q38299938-97D50C66-847A-4A39-AF1D-9FDD9920AA77Q38417606-D751C255-5672-47D2-A295-24F1E6FF83C8Q38619615-C15A643C-6890-4261-8982-852B6DA922FFQ38637145-C21BDE35-DC62-48B0-A717-577EF4B7165EQ38722225-3E95D2AD-6D5E-4FD4-A258-D6E6A6EA94D8Q38834040-986DA1F4-4B01-49C9-9BB8-62ADF3652A3BQ38860973-BA0C9990-0464-406F-B62B-821C5C0471FBQ38945520-D1DA1039-609B-4C26-9B5D-D50BA03E29E1Q38965040-82B5AAC3-F5F6-41E8-B94D-F91DD9A92321Q39107981-E40FEAFE-B882-4894-9A3C-42F64BAD94F8Q39163758-69E0E042-6EB3-4AD3-A090-E7E629752A55Q40613300-555ECACB-6626-4D3A-9436-691E364E4051Q41247863-5C2D79CF-DA17-4061-873B-A9EFFD66BE3BQ42106679-44FED817-3F32-436A-8E47-3733868A1171Q46504220-EEFE5B1D-0C00-4698-BDD9-D162D404E8A6Q47152593-5314FB69-244A-44A5-9964-F790DF3DBA2BQ47690946-D9745F1C-2B4B-4537-B997-C843926A6DFBQ48167225-19BCCF13-7F75-4444-9E4B-A6C8091838C7Q48263793-71501689-69FC-4CD1-88EA-F7406E8A2A34Q49689767-8F6A88A9-C99E-45C3-A679-8DE83538BE51Q50214807-399C8A8A-3F47-4C88-901B-C09EE2E13700Q50724133-1C41B941-6CD4-4518-BE40-E444B6838A19Q51220154-EA4D3026-B158-4850-A9E8-48DEBF45C779Q52673303-199D0E5A-6BFA-4FFC-B09E-3D83AD6E5D31Q52719267-4F99A491-5568-435A-815A-03722544D440Q54225215-2F0F4646-1A0D-44B0-8F2E-EA9B40B27A43Q54960575-881BB268-0BE1-466C-A136-4042FEF17559Q54965855-A83B1DCE-5471-494D-A02C-DF0D8A41A278
P2860
Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@ast
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en-gb
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@nl
type
label
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@ast
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en-gb
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@nl
prefLabel
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@ast
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en-gb
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@nl
P2093
P2860
P50
P921
P3181
P356
P1476
Identification of a ZEB2-MITF- ...... nesis and melanoma progression
@en
P2093
B De Craene
J van den Oord
P2860
P2888
P304
P3181
P356
10.1038/CDD.2014.44
P407
P50
P577
2014-04-25T00:00:00Z
P6179
1014995861